The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)

Future Med Chem. 2021 Mar;13(6):587-592. doi: 10.4155/fmc-2020-0226. Epub 2021 Jan 20.

Abstract

Understanding the potential association between the poly (ADP-ribose) polymerase member 14 (PARP14) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may aid in understanding the host immunopathological response to the virus. PARP14 has an emerging role in viral infections, and this article considers its potential mechanisms for action in either a pro- or anti-viral manner. It is evident that more experimental work is required; however, PARP14 appears vital in controlling the interferon response to the SARS-CoV-2 infection and has potential roles in balancing the proinflammatory cytokines of the cytokine storm. Furthermore, the SARS-CoV-2 macrodomain can prevent the PARP14-mediated antiviral response, suggesting a more complex relationship between PARP14 activity and SARS-CoV-2 infections.

Keywords: ARTD8; COVID-19; PARP14; SARS-CoV-2; coronavirus; immunity; viral.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / complications
  • COVID-19 / immunology*
  • COVID-19 / pathology
  • Cytokine Release Syndrome / complications
  • Cytokine Release Syndrome / immunology
  • Cytokine Release Syndrome / pathology
  • Humans
  • Immunity
  • Inflammation / complications
  • Inflammation / immunology
  • Inflammation / pathology
  • Interferons / immunology
  • Poly(ADP-ribose) Polymerases / immunology*
  • SARS-CoV-2 / immunology*

Substances

  • Interferons
  • PARP14 protein, human
  • Poly(ADP-ribose) Polymerases

Grants and funding